Literature DB >> 8889679

Detection of amphetamine following administration of fenproporex.

J T Cody1, S Valtier.   

Abstract

Drugs that are metabolized to amphetamine or methamphetamine are potentially significant concerns in the interpretation of amphetamine-positive drug testing results. A number of different compounds have been reported to produce amphetamine in the urine of users. One of these compounds, fenproporex, has been shown to produce amphetamine. Previous reports indicate that the parent compound can be detected only for a few hours following administration, whereas the amphetamine can be detected for several days. Administration of fenproporex to five healthy volunteers resulted in amphetamine being detected in the urine of all subjects. Peak concentrations of amphetamine were detected at approximately 6-20 h postdose and ranged from approximately 1200 to 2100 ng/mL amphetamine. Amphetamine could be detected (> 5 ng/mL) in the urine for up to 119 h. Analysis of the metabolically produced amphetamine showed the presence of both enantiomers, which can be helpful in the differentiation of some illicit amphetamine use from the use of this precursor drug. More significantly, all samples that contained amphetamine at a concentration of at least 500 ng/mL were shown to also contain measurable amounts of the parent compound.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889679     DOI: 10.1093/jat/20.6.425

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

Review 1.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  A Molecularly Imprinted Polymer-based Dye Displacement Assay for the Rapid Visual Detection of Amphetamine in Urine.

Authors:  Joseph W Lowdon; Kasper Eersels; Rocio Arreguin-Campos; Manlio Caldara; Benjamin Heidt; Renato Rogosic; Kathia L Jimenez-Monroy; Thomas J Cleij; Hanne Diliën; Bart van Grinsven
Journal:  Molecules       Date:  2020-11-10       Impact factor: 4.411

Review 3.  Safety and efficacy of fenproporex for obesity treatment: a systematic review.

Authors:  Francisco José Roma Paumgartten; Sabrina Schaaf Teixeira Costa Pereira; Ana Cecilia Amado Xavier de Oliveira
Journal:  Rev Saude Publica       Date:  2016-05-24       Impact factor: 2.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.